Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly: Therapeutic Considerations (Part I)

Clinical Pharmacokinetics

Volumn 21, Issue 3, 1991, Pages 165-177

  Greenblatt, David J ^a,b   Harmatz, Jerold S ^a,b   Shader, Richard I ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BROTIZOLAM; BUSPIRONE; CHLORDIAZEPOXIDE; CLOBAZAM; CLOTIAZEPAM; DEALKYLFLURAZEPAM; DIAZEPAM; HYPNOTIC AGENT; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MIDAZOLAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; TEMAZEPAM; TRIAZOLAM;

AGED; BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; REVIEW;

AGED; AGING; ANTI-ANXIETY AGENTS; HUMAN; HYPNOTICS AND SEDATIVES;

EID: 0025830898     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199121030-00002     Document Type: Review

References (0)